Trials / Recruiting
RecruitingNCT06828276
Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants
Culturally and Language-Adapted i-CBT for Common Mental Health Problems: A Randomized Controlled Study With Farsi/Dari-Speaking Migrants
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 15 Years – 29 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.
Detailed description
Participants who are included in the study will be allocated to the experimental group and the control group (waiting list). Participants will be invited to participate tailored i-CBT intervention over 10-weeks. Intervention covers common psychological issues. Participants will have access to support through a chatting function, during the interventional period. Intervention effects will be measured prior-treatment, post-treatment, and 6 months post-treatment.
Conditions
- Depressive Symptoms
- Anxiety Symptoms
- Grief
- Psychological Trauma
- Insomnia
- Resilience
- Stress
- Psychological Well Being
- Marital Relationship
- Wellbeing
- Common Mental Health Problems
- Rumination
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Culturally adapted i-CBT | A culturally and language adapted i-CBT intervention for Farsi/Dari speaking youth migrants and refugees. The intervention targets mild to moderate common mental health problems. |
Timeline
- Start date
- 2025-03-25
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-02-14
- Last updated
- 2025-12-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06828276. Inclusion in this directory is not an endorsement.